NBIX
Neurocrine Biosciences Inc
143.50$
-1.4%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.10 | 1.21 | 1.26 | 0.62 | 1.51 | 2.36 | 0.63 | 1.01 | 2.22 | 3.79 | 1.41 | 1.31 | 8.62 | |
| 0.05 | 0.06 | 0.06 | 0.07 | 0.06 | 0.07 | 0.07 | 0.07 | 0.08 | 0.07 | 0.07 | 0.24 | 0.45 | |
| 0.47 | 0.37 | 0.43 | 0.41 | 0.40 | 0.65 | 0.52 | 0.52 | 0.52 | 0.57 | 0.55 | 0.62 | 2.25 | |
| 0.45 | -0.52 | -0.31 | -0.83 | 0.04 | 0.92 | -0.23 | -0.39 | -1.81 | 1.16 | -0.03 | -0.77 | -1.43 | |
| 0.08 | 0.05 | 0.11 | 0.11 | 0.08 | 0.07 | 0.10 | 0.12 | 0.13 | 0.02 | 0.09 | 0.07 | 0.31 | |
| -0.96 | -1.97 | -0.53 | -0.27 | 0.24 | -0.66 | 0.14 | -0.29 | -1.92 | -0.52 | -4.90 | -1.30 | -8.55 | |
| – | – | 0.00 | 0.00 | – | -2.92 | -1.46 | -0.18 | 0.00 | 0.00 | -0.52 | -0.12 | -0.63 | |
| – | – | – | – | 0.00 | 0.00 | – | – | 0.00 | 0.00 | – | – | – | |
| 0.19 | 0.35 | 0.67 | -2.82 | 0.25 | -2.82 | -1.15 | -0.03 | 0.44 | 0.36 | -0.83 | 0.61 | 0.58 | |
| 1.32 | -0.42 | 1.40 | -2.47 | 2.01 | -1.13 | -0.38 | 0.69 | 0.74 | 3.64 | -4.32 | 0.62 | 0.64 | |
| 2.02 | 1.15 | 1.15 | 0.51 | 1.44 | 2.29 | 0.53 | 0.89 | 2.09 | 3.81 | 1.32 | 1.23 | 8.35 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.